- Home
- FINS vs SPRC Comparison
FINS vs SPRC Comparison
Compare FINS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINS
- SPRC
- Stock Information
- Founded
- FINS 2019
- SPRC 2004
- Country
- FINS United States
- SPRC Israel
- Employees
- FINS N/A
- SPRC N/A
- Industry
- FINS Finance/Investors Services
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- FINS Finance
- SPRC Health Care
- Exchange
- FINS Nasdaq
- SPRC Nasdaq
- Market Cap
- FINS 447.8M
- SPRC 3.0M
- IPO Year
- FINS N/A
- SPRC N/A
- Fundamental
- Price
- FINS $13.18
- SPRC $4.47
- Analyst Decision
- FINS
- SPRC
- Analyst Count
- FINS 0
- SPRC 0
- Target Price
- FINS N/A
- SPRC N/A
- AVG Volume (30 Days)
- FINS 78.0K
- SPRC 7.6M
- Earning Date
- FINS 01-01-0001
- SPRC 01-01-0001
- Dividend Yield
- FINS 9.97%
- SPRC N/A
- EPS Growth
- FINS N/A
- SPRC N/A
- EPS
- FINS N/A
- SPRC N/A
- Revenue
- FINS N/A
- SPRC $1,306,000.00
- Revenue This Year
- FINS N/A
- SPRC N/A
- Revenue Next Year
- FINS N/A
- SPRC N/A
- P/E Ratio
- FINS N/A
- SPRC N/A
- Revenue Growth
- FINS N/A
- SPRC N/A
- 52 Week Low
- FINS $11.61
- SPRC $1.75
- 52 Week High
- FINS $12.57
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- FINS 45.68
- SPRC 61.66
- Support Level
- FINS $13.20
- SPRC $1.76
- Resistance Level
- FINS $13.55
- SPRC $1.95
- Average True Range (ATR)
- FINS 0.13
- SPRC 0.51
- MACD
- FINS -0.01
- SPRC 0.20
- Stochastic Oscillator
- FINS 11.67
- SPRC 59.00
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.